{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T06:02:19Z","timestamp":1782885739635,"version":"3.54.5"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>We evaluated the effectiveness of annual LTBI screening via IGRA in people with HIV in non-endemic settings over 5 years. Out of 1898 patients with at least 2 IGRAs, only 12 developed new LTBI, highlighting the low yield of universal screening. Findings support targeted screening per current guidelines.<\/jats:p>","DOI":"10.1093\/ofid\/ofag227","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T11:47:53Z","timestamp":1781783273000},"source":"Crossref","is-referenced-by-count":0,"title":["Is There Value in Performing Yearly Screening for Latent Tuberculosis Infection by Interferon-Gamma Release Assay Among Patients Living With HIV in Non-Endemic Settings?"],"prefix":"10.1093","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2698-981X","authenticated-orcid":false,"given":"Carlo","family":"Foppiano Palacios","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Cooper Medical School of Rowan University , Camden, New Jersey ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8954-345X","authenticated-orcid":false,"given":"Amit","family":"Achhra","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases, Department of Medicine, Yale School of Medicine , New Haven, Connecticut ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4994-2907","authenticated-orcid":false,"given":"Lydia","family":"Barakat","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases, Department of Medicine, Yale School of Medicine , New Haven, Connecticut ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Virata","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases, Department of Medicine, Yale School of Medicine , New Haven, Connecticut ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritche","family":"Hao","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases, Department of Medicine, Yale School of Medicine , New Haven, Connecticut ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0704-9603","authenticated-orcid":false,"given":"John","family":"Baxter","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Cooper Medical School of Rowan University , Camden, New Jersey ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5720-9994","authenticated-orcid":false,"given":"Maricar","family":"Malinis","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center , Nashville, Tennessee ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"key":"2026063011221351900_ofag227-B1","author":"World Health Organization"},{"key":"2026063011221351900_ofag227-B2","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1093\/infdis\/jiw085","article-title":"Incidence of AIDS-defining opportunistic infections in a multicohort analysis of HIV-infected persons in the United States and Canada, 2000-2010","volume":"214","author":"Buchacz","year":"2016","journal-title":"J Infect Dis"},{"key":"2026063011221351900_ofag227-B3","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.76","article-title":"Tuberculosis","volume":"2","author":"Pai","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"2026063011221351900_ofag227-B4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/cid\/ciw778","article-title":"Official American Thoracic Society\/Infectious Diseases Society of America\/Centers for Disease Control and prevention clinical practice guidelines: diagnosis of Tuberculosis in adults and children","volume":"64","author":"Lewinsohn","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2026063011221351900_ofag227-B5","author":"World Health Organization"},{"key":"2026063011221351900_ofag227-B6"},{"key":"2026063011221351900_ofag227-B7","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJM198903023200901","article-title":"A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection","volume":"320","author":"Selwyn","year":"1989","journal-title":"N Engl J Med"},{"key":"2026063011221351900_ofag227-B8","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1056\/NEJMsa031667","article-title":"Priorities for the treatment of latent tuberculosis infection in the United States","volume":"350","author":"Horsburgh","year":"2004","journal-title":"N Engl J Med"},{"key":"2026063011221351900_ofag227-B9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00126334-200001010-00010","article-title":"Risk factors for developing tuberculosis in HIV-1-infected adults from communities with a low or very high incidence of tuberculosis","volume":"23","author":"Wood","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2026063011221351900_ofag227-B10","article-title":"Treatment of latent tuberculosis infection in HIV infected persons","volume":"2010","author":"Akolo","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"2026063011221351900_ofag227-B11","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa1507198","article-title":"A trial of early antiretrovirals and isoniazid preventive therapy in Africa","volume":"373","author":"Group","year":"2015","journal-title":"N Engl J Med"},{"key":"2026063011221351900_ofag227-B12","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1016\/S2352-3018(20)30299-X","article-title":"Isoniazid preventive therapy plus antiretroviral therapy for the prevention of tuberculosis: a systematic review and meta-analysis of individual participant data","volume":"8","author":"Ross","year":"2021","journal-title":"Lancet HIV"},{"key":"2026063011221351900_ofag227-B13","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw694","article-title":"Official American Thoracic Society\/Infectious Diseases Society of America\/Centers for Disease Control and prevention clinical practice guidelines: diagnosis of Tuberculosis in adults and Children","volume":"64","author":"Lewinsohn","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2026063011221351900_ofag227-B14","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.5588\/ijtld.17.0041","article-title":"Latent tuberculous infection testing among HIV-infected persons in clinical care, United States, 2010-2012","volume":"21","author":"Reaves","year":"2017","journal-title":"Int J Tuberc Lung Dis"},{"issue":"RR-5","key":"2026063011221351900_ofag227-B15","first-page":"1","article-title":"Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection - United States, 2010","volume":"59","author":"Mazurek","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"2026063011221351900_ofag227-B16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4046\/trd.2017.0072","article-title":"Comparison of interferon-gamma release assays and the tuberculin skin test for diagnosis of Tuberculosis in Human Immunodeficiency Virus: a systematic review","volume":"81","author":"Overton","year":"2018","journal-title":"Tuberc Respir Dis (Seoul)"},{"key":"2026063011221351900_ofag227-B17","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/infdis\/jit418","article-title":"Reversion and conversion of interferon-gamma release assay results in HIV-1-infected individuals","volume":"209","author":"Aichelburg","year":"2014","journal-title":"J Infect Dis"},{"key":"2026063011221351900_ofag227-B18","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1093\/infdis\/jiv038","article-title":"Immune Status and serial quantiferon-TB gold in-tube screening for latent Mycobacterium tuberculosis infection among HIV-infected persons in a country with a low Tuberculosis incidence","volume":"211","author":"Sane Schepisi","year":"2015","journal-title":"J Infect Dis"},{"key":"2026063011221351900_ofag227-B19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235986","article-title":"Serial testing of health care workers for tuberculosis infection: a prospective cohort study","volume":"15","author":"Casas","year":"2020","journal-title":"PLoS One"},{"key":"2026063011221351900_ofag227-B20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1378\/chest.11-0992","article-title":"Challenges of interferon-gamma release assay conversions in serial testing of health-care workers in a TB control program","volume":"142","author":"Fong","year":"2012","journal-title":"Chest"},{"key":"2026063011221351900_ofag227-B21","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1164\/rccm.200604-472OC","article-title":"Serial testing of health care workers for tuberculosis using interferon-gamma assay","volume":"174","author":"Pai","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"2026063011221351900_ofag227-B22","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1093\/cid\/cir792","article-title":"Identification of false-positive QuantiFERON-TB gold in-tube assays by repeat testing in HIV-infected patients at low risk for tuberculosis","volume":"54","author":"Gray","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2026063011221351900_ofag227-B23","author":"Centers for Disease Control and Prevention"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/6\/ofag227\/68557974\/ofag227.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/6\/ofag227\/68557974\/ofag227.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T04:45:10Z","timestamp":1782881110000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofag227\/8711575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,2]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofag227","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,6]]},"article-number":"ofag227"}}